Clinical trial
Clinical Outcomes of VIGIV Treatment of Smallpox Vaccination Complications or Vaccinia Infection
NCT01374984 is registered in ClinicalTrials.gov with Emergent BioSolutions as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Outcomes of VIGIV Treatment of Smallpox Vaccination Complications or Vaccinia Infection
- Lead sponsor
- Emergent BioSolutions
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- August 31, 2007
- Completion date
- August 31, 2028
- Enrollment
- 100 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
complication of smallpox vaccination